Document is current
Any future updates will be listed below
-
Authors
Perfetto, Federico https://orcid.org/0000-0003-0276-8331
Zampieri, Mattia https://orcid.org/0000-0002-1140-134X
Fumagalli, Carlo https://orcid.org/0000-0001-7963-5049
Allinovi, Marco https://orcid.org/0000-0001-9949-3543
Cappelli, Francesco https://orcid.org/0000-0002-1622-0732
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 23 February 2022
First Online: 24 March 2022
Declarations
:
: The author(s) declare that they have no conflict of interest.
: The manuscript is not a clinical study, but an up to date review aimed to summarize the current clinical use of circulating biomarkers for the management of cardiac amyloidosis, collecting and discussing the current literature on this topic. Thus, the authors have not directly involved humans and/or animals in the drafting of the manuscript.
